All lots of JAMP-Mycophenolate 250 mg capsules recalled due to possible incorrect dose, which may pose health risks
Why it was recalled
Product safety
What you should do
If you are taking this medication, speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected by the recall and provide a replacement if needed. Given the capsule format, it is not possible to know whether your capsule is overweight or underweight by looking at it.Continue taking your medication until you speak with your pharmacist, as mycophenolate is an important drug in preventing organ rejection in kidney, heart or liver transplant patients.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.